UNASSIGNED: We conducted a retrospective analysis of patients who underwent tumescent-free robotic NSM between October 2020 and March 2023 at Asan Medical Center (Seoul, Korea). Clinicopathological characteristics, adverse events, and operative time were evaluated.
UNASSIGNED: During the study period, 118 patients underwent tumescent-free robotic NSM. Thirty-one patients (26.3%) experienced an adverse event. Five patients (4.2%) were classified as grade III based on the Clavien-Dindo classification and required surgery. The mean total operative time was 467 minutes for autologous tissue reconstruction (n = 49) and 252 minutes for implants (n = 69). No correlation was found between the cumulative number of surgical cases and the breast operative time (P = 0.30, 0.52, 0.59 for surgeons A, B, C) for the 3 surgeons. However, a significant linear relationship (P < 0.001) was observed, with the operative time increasing by 13 minutes for every 100-g increase in specimen weight.
UNASSIGNED: Tumescent-free robotic NSM is a safe procedure with a feasible operative time and few adverse events.
■我们对2020年10月至2023年3月在Asan医疗中心接受无肿胀机器人NSM的患者进行了回顾性分析(首尔,韩国)。临床病理特征,不良事件,评估手术时间。
■在研究期间,118例患者接受了无肿胀机器人NSM。31例患者(26.3%)发生不良事件。根据Clavien-Dindo分类,五名患者(4.2%)被分类为III级,需要手术。自体组织重建的平均总手术时间为467分钟(n=49),植入物的平均总手术时间为252分钟(n=69)。累计手术例数与乳腺手术时间无相关性(术者A,P=0.30,0.52,0.59,B,C)为3名外科医生。然而,观察到显著的线性关系(P<0.001),标本重量每增加100-g,手术时间增加13分钟。
■无肿胀机器人NSM是一种安全的程序,具有可行的手术时间和很少的不良事件。